Glucuronidation converts clopidogrel to a strong time-dependent inhibitor of CYP2C8: a phase II metabolite as a perpetrator of drug-drug interactions.

A Tornio, AM Filppula, O Kailari, M Neuvonen, TH Nyrönen, T Tapaninen, PJ Neuvonen, Mikko Niemi, JT Backman

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalClinical Pharmacology and Therapeutics
DOIs
Publication statusPublished - Oct 2014
MoE publication typeA1 Journal article-refereed

Cite this